ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Taiho Sends Benz LSD1 Inhibitor Fo
Generics BulletinLupin will have to wait until at least January 2030 to launch its proposed generic version of Harmony Biosciences’ Wakix (pitolisant hydrochloride) in the US after agreeing to settle patent-infringeme
Generics BulletinLupin has struck a license and supply agreement with Latin American firm SteinCares for the commercialization of Lupin’s ranibizumab biosimilar rival to Lucentis across the Latin America region. Stein
Generics BulletinMarket dynamics in the US have assumed an unprecedented level of unpredictability as President Donald Trump shakes things up with a most favored nation (MFN) policy, tariff proposals, staff cuts at th